Informações bibliográficas
DiretrizWHO guidelines on leishmaniases: treatment of visceral leishmaniasis and post-kala-azar dermal leishmaniasis in eastern Africa and South-East Asia
Ano de publicação2026
Instituição emissoraWorld Health Organization
Recomendação
Nova
Visceral leishmaniasis (VL) relapse in South-East Asia. When available, a combination of drugs (co-administered) can be used to treat relapse cases. ⸋ miltefosine plus paromomycin, both daily for 10 days ⸋ liposomal amphotericin B (LAmB) (5 mg/kg by infusion, single dose) plus miltefosine (daily for 7 days) ⸋ LAmB (5 mg/kg by infusion, single dose) plus paromomycin (daily for 10 days)
Recomendado a favor
Condicional
Certeza da evidência
Muito baixa